Enhanced Expression of DNA Topoisomerase II by Recombinant Human Granulocyte Colony-stimulating Factor in Human Leukemia Cells

Masayuki Towatari, Yoshinori Ito, Yoshihisa Morishita, Mitsune Tanimoto, Kohei Kawashima, Yasuo Morishima, Hidehiko Saito, Toshiwo Andoh

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)


The effect of recombinant human granulocyte colony-stimulating factor (G-CSF) on DNA topoisomerase II (topo II) expression was studied in two human acute myelogenous leukemia cell lines, NKM-1 and NOMO-1, which express G-CSF receptor and proliferate in response to exogenous G-CSF. Northern blot analysis revealed that the level of topo II mRNA in 16-h stimulated cells in serum-free medium with G-CSF (10 ng/ml) was approximately 2-fold higher than that in cells without G-CSF. Enhanced topo II mRNA expression was detectable within 3 h after the addition of G-CSF. Topo II activity in crude nuclear extracts from 16-h G-CSF-stimulated cells was also found to be approximately 2-fold greater than that from unstimulated cells. According to in vitro cytotoxic assay, the sensitivity of G-CSF-stimulated cells to intercalating (daunorubicin) and nonintercalating (etoposide) topo II-targeting drugs increased significantly, whereas no enhancement of sensitivity was observed with an alkylating agent (4-hydroperoxycyclophosphamide). The augmented drug sensitivity observed was not due to the increased level of drug transport, as suggested by the similar extent of [3H]etoposide uptake between G-CSF-stimulated and unstimulated cells. By measuring the topo II mRNA and the cytotoxicity of the above mentioned drugs, we obtained essentially the same results in G-CSF-responsive leukemia cells isolated from three acute myeloblastic leukemia patients, as observed in the cultured cell lines. These findings strongly suggest that the sensitivity to “topo II-targeting drugs” could be augmented by exogenous G-CSF through elevated topo II activity in G-CSF-responsive leukemia cells.

Original languageEnglish
Pages (from-to)7198-7202
Number of pages5
JournalCancer Research
Issue number22
Publication statusPublished - Nov 12 1990
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Enhanced Expression of DNA Topoisomerase II by Recombinant Human Granulocyte Colony-stimulating Factor in Human Leukemia Cells'. Together they form a unique fingerprint.

Cite this